mva.thivconsv4
Vaccineexperimental
Clinical trial activity
1 trials · 8 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Oct 19, 2020 (NCT04553016)
Timeline
2020s
- Jan 1, 2020
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Human immunodeficiency virusImmunity, active
Human immunodeficiency virus immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04553016 | Phase 1 | Oct 19, 2020 | Center for Family Health Research in Zambia, European and Developing Countries Clinical Trials Partnership (EDCTP), Imperial College London, International AIDS Vaccine Initiative, Medical Research Council, University of Nairobi, University of Oxford, Wellcome Trust |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (8)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Center for Family Health Research in Zambia | Academic/Hospital | 1 | 0 | 1 | 2020 |
| European and Developing Countries Clinical Trials Partnership (EDCTP) | Academic/Hospital | 1 | 0 | 1 | 2020 |
| Imperial College London | Academic/Hospital | 1 | 0 | 1 | 2020 |
| International AIDS Vaccine Initiative | Academic/Hospital | 1 | 0 | 1 | 2020 |
| Medical Research Council | Government | 1 | 0 | 1 | 2020 |
| University of Nairobi | Academic/Hospital | 1 | 0 | 1 | 2020 |
| University of Oxford | Academic/Hospital | 1 | 1 | 1 | 2020 |
| Wellcome Trust | Academic/Hospital | 1 | 0 | 1 | 2020 |
8 organizations
Page 1 / 1